GOT2 and invasive ductal breast carcinoma: Recent data implicate lipid metabolism in ILC, with ILC expressing more fatty acid binding protein than invasive ductal carcinoma, and factors related to lipid metabolism being involved in endocrine resistance in ILC [25–27].